ArticlebioRxiv : the preprint server for biology2026
APRIL: Adaptive Regression-Based Two-Dimensional Quantitative Anisotropy Imaging Using Acoustic Radiation Force Impulse.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Objective: This study aims to develop and validate a quantitative, depth-resolved anisotropy imaging framework that extends ARFI-based focal degree-of-anisotropy (DoA) estimation into two-dimensional mapping by modeling the depth-dependent relationship between shear modulus ratio (SMR) and peak displacement ratio (PDR). Methods: We propose APRIL (Adaptive Polynomial Regression for anisotropy Imaging via ARFI-induced DispLacements), a framework for quantitative, depth-resolved DoA imaging that adaptively selects polynomial regression or shape-preserving spline interpolation based on excitation PSF asymmetry. Training data were generated using an LS-DYNA3D + Field II simulation pipeline in homogeneous transversely isotropic media (SMR 0.9-4.9). Testing included shifted SMRs under varied acoustic conditions and three heterogeneous inclusion configurations (anisotropic inclusion in isotropic background and vice versa). Experimental validation was performed in an in-vivo murine tumor model over the time, ex-vivo chicken breast, and tissue-mimicking gelatin phantoms, using a Verasonics system with an L11-5v transducer. Results: APRIL achieved depth-resolved SMR prediction errors below 9% over 10-30 mm, with highest accuracy in the focal region (MAE 2.3%, RMSE < 0.1) and stable performance across PSF transition zones. In heterogeneous phantoms, it reconstructed anisotropy maps with SSIM up to 86% and MPE below 7%, accurately delineating inclusion boundaries. Under acoustic parameter variations, mean absolute errors remained below 10%, demonstrating robustness to system and tissue heterogeneity. Conclusion: APRIL enables robust, two-dimensional anisotropy imaging beyond focal estimates. Significance: The method provides a physically grounded and generalizable framework for clinically viable anisotropy biomarkers in muscle, tendon, kidney, tumor and breast tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.